CD8A and COVID-19: Using in silico-predicted HLA-class I and II peptide pools, CD4+ T cell responses to SARS-CoV-2 were demonstrated in all volunteers who had recovered from COVID-19 and CD8+ responses were demonstrated in 70%10.